Westlake Medical Research   Report issue

For profit Phase 2 Phase 3
Founded: Thousand Oaks CA United States (1996)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2007
NCT00453401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (4)

chickpea (1 trial)

lactobacillus casei (1 trial)

traumeel (1 trial)

zeel (1 trial)

Drugs in Phase 2 Trials (1)

nb-001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Labialis (Phase 2)

Irritable Bowel Syndrome (Phase 3)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5